Aquaculture

Bluefront acquires 80% stake in Cryogenetics

2024-10-21T14:11:00

Rainbow trout hatched

Source: Cryogenetics

Bluefront Equity has announced its biggest ever investment with the majority acquisition of aquaculture technology specialist, Cryogenetics

Through its Capital II fund Bluefront will own around 80% of shares with the remainder split between co-owner, Investinor, and Cryogenetics managing director, Eli Sætersmoen.

The plan is to increase investment in the farming of salmon, halibut, trout, wolffish and cod, both in Norway and internationally.

Continue this article…

Already subscribed? SIGN IN now

wf_web_image

Sign up for FREE to continue this article!

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy:

  • Weekly newsletters providing valuable news and information on the commercial fishing and aquaculture sector
  • Full access to our news archive
  • Live and archived webinars, podcasts and videos
  • Articles on innovations and current trends in the commercial fishing industry
  • Our extensive archive of data, research and intelligence

Get more free content sign up today

Ready to subscribe? Choose from one of our subscription packages for unlimited access!